Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Polymyalgia Rheumatica

• Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica
• Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR
• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
• Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
• Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse
• Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed
• A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)
• Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
• Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission
• A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154
• Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement
• Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers
• GCs Sparing Regimen in PMR
• A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis
• Abatacept for the Treatment of Giant Cell Arteritis
• Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA
• Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
• BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica
• Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).
• MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial
• Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
• KPL-301 for Subjects With Giant Cell Arteritis
• A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis
• Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
• Tocilizumab Plus a Short Prednisone Taper for GCA
• A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
• Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis
• Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
• Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS
• Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
• Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
• Treatment With Leflunomide in Patients With Polymyalgia Rheumatica
• Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
• A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)
• An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)
• A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
• Baricitinib in Relapsing Giant Cell Arteritis
• Ustekinumab for the Treatment of Giant Cell Arteritis
• Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE
• Giant Cell Arteritis and Anakinra Trial
• Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica
• Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
• Delayed Release Prednisone in PMR
• Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
• Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.
• A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR
• An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)
• Tocilizumab Effect iN pOlymyalgia Rheumatica
• Tocilizumab for Patients With Giant Cell Arteritis
• Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica
• Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
• Study of Tocilizumab to Treat Polymyalgia Rheumatica
• A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica
• Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients
• Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia Rheumatica
• Timed Release Tablet Prednisone in Polymyalgia Rheumatica
• Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
• Etanercept Treatment in the Early Course of Polymyalgia Rheumatica
• Hydroxychloroquine in Giant Cell Arteritis
• HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis
• Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
• A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
• Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis